|
C1ORF96 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.193200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.887400E-01 |
| Normal-vs-Stage2 |
1.632650E-01 |
| Normal-vs-Stage3 |
9.625600E-02 |
| Normal-vs-Stage4 |
2.014400E-01 |
| Stage1-vs-Stage2 |
2.512200E-02 |
| Stage1-vs-Stage3 |
3.748500E-02 |
| Stage1-vs-Stage4 |
1.557950E-01 |
| Stage2-vs-Stage3 |
7.672000E-01 |
| Stage2-vs-Stage4 |
4.218600E-01 |
| Stage3-vs-Stage4 |
5.094800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.063600E-01 |
| Normal-vs-AfricanAmerican |
4.117800E-01 |
| Normal-vs-Asian |
1.132450E-01 |
| Caucasian-vs-AfricanAmerican |
6.664800E-01 |
| Caucasian-vs-Asian |
1.425150E-01 |
| AfricanAmerican-vs-Asian |
3.584800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.256400E-01 |
| Normal-vs-Female |
2.456600E-03 |
| Male-vs-Female |
7.820100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.994800E-01 |
| Normal-vs-Extreme_Weight |
2.151600E-01 |
| Normal-vs-Obese |
2.234000E-01 |
| Normal-vs-Extreme_Obese |
2.355800E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.944500E-02 |
| Normal_Weight-vs-Obese |
9.854400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.117400E-03 |
| Extreme_Weight-vs-Obese |
4.780500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.261800E-02 |
| Obese-vs-Extreme_Obese |
4.582300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.925900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.441810E-01 |
| Normal-vs-Age(61-80Yrs) |
5.436400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.337400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.961700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.785600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.620100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.673700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.064400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.236800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.308170E-01 |
| Normal-VS-Type2 PRCC |
8.807400E-01 |
| Normal-VS-KIRP CIMP |
1.079330E-03 |
| Normal-VS-Unclassified PRCC |
5.962300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.834600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.186000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.267590E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.604300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.840200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.553050E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.820400E-01 |
| Normal-vs-N1 |
7.217400E-03 |
| Normal-vs-N2 |
5.319200E-01 |
| N0-vs-N1 |
6.902600E-03 |
| N0-vs-N2 |
5.199000E-01 |
| N1-vs-N2 |
5.151000E-01 |
|
|
